摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Chloro-4-(3,4-dichloro-phenylsulfanyl)-phenylamine | 32631-30-4

中文名称
——
中文别名
——
英文名称
3-Chloro-4-(3,4-dichloro-phenylsulfanyl)-phenylamine
英文别名
3-Chloro-4-(3,4-dichlorophenyl)sulfanylaniline
3-Chloro-4-(3,4-dichloro-phenylsulfanyl)-phenylamine化学式
CAS
32631-30-4
化学式
C12H8Cl3NS
mdl
MFCD21536498
分子量
304.627
InChiKey
ZLCGBQNOMIJNOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    51.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
    申请人:McGee Lawrence R.
    公开号:US20100113522A1
    公开(公告)日:2010-05-06
    Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.
    提供了PPARγ活性调节剂,可用于制备药物组合物和治疗2型糖尿病和肥胖等疾病的方法。
  • INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
    申请人:ICOS CORPORATION
    公开号:EP1165504A2
    公开(公告)日:2002-01-02
  • US7626033B2
    申请人:——
    公开号:US7626033B2
    公开(公告)日:2009-12-01
  • US7968567B2
    申请人:——
    公开号:US7968567B2
    公开(公告)日:2011-06-28
  • [EN] INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF<br/>[FR] INHIBITEURS DE LA LIAISON DE LFA-1 A DES ICAMS ICAMS ET LIEURS UTILISATIONS
    申请人:ICOS CORP
    公开号:WO2000059878A2
    公开(公告)日:2000-10-12
    The present invention is directed to compounds that bind to a novel regulatory site in the I domain of LFA-1, and thereby inhibit LFA-1 binding to ICAMs that bind LFA-1. The present invention therefore also provides methods to regulate leukocyte adhesion to endothelial cells. Compounds of the ivnention are useful for the treatment of pathologies, such as those associated inflammatory diseases, autoimmune diseases, tumor metastasis, allograft rejection and reperfusion injury. In particular, the present invention is directed to diaryl sulfides of general structural formula (I), a pharmaceutically acceptable salt, or prodrug thereof, and to the use of diaryl sulfides, and particularly compounds of formula (I), to inhibit LFA-1 binding to an ICAM that binds LFA-1 wherein A and B, independently, are aryl groups selected from the group consisting of 5- and 6-membered aromatic rings, including, but not limited to, phenyl, thienyl, furyl, pyrimidinyl, imidazolyl, pyrazolyl, pyridyl, pyrazinyl, pyrrolyl, and pyridazinyl.
查看更多